MEDIDATA SOLUTIONS INC (MDSO) Stock Price, Quote, News and Overview
NASDAQ:MDSO - Nasdaq -
MDSO Quote, Performance and Key Statistics
92.22
-0.02 (-0.02%)
The current stock price of MDSO is 92.22 null. In the past month the price increased by 0.79%. In the past year, price increased by 28.57%.
About MDSO
Company Profile
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
Company Info
MEDIDATA SOLUTIONS INC
350 HUDSON ST. 9TH FLOOR
NEW YORK NY 10014
CEO: Tarek A. Sherif
Phone: 212-918-1800
MEDIDATA SOLUTIONS INC / MDSO FAQ
What is the stock price of MEDIDATA SOLUTIONS INC today?
The current stock price of MDSO is 92.22 null. The price decreased by -0.02% in the last trading session.
What is the ticker symbol for MEDIDATA SOLUTIONS INC stock?
The exchange symbol of MEDIDATA SOLUTIONS INC is MDSO and it is listed on the Nasdaq exchange.
On which exchange is MDSO stock listed?
MDSO stock is listed on the Nasdaq exchange.
What is MEDIDATA SOLUTIONS INC worth?
MEDIDATA SOLUTIONS INC (MDSO) has a market capitalization of 5.76B null. This makes MDSO a Mid Cap stock.
What are the support and resistance levels for MEDIDATA SOLUTIONS INC (MDSO) stock?
MEDIDATA SOLUTIONS INC (MDSO) has a support level at 92.09 and a resistance level at 93.97. Check the full technical report for a detailed analysis of MDSO support and resistance levels.
Should I buy MEDIDATA SOLUTIONS INC (MDSO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MDSO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MDSO, evaluating the profitability, health, valuation and growth aspects
- MEDIDATA SOLUTIONS INC (MDSO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDIDATA SOLUTIONS INC (MDSO) Sales and EPS estimates to see what analysts future expectations are.
- MEDIDATA SOLUTIONS INC (MDSO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDIDATA SOLUTIONS INC (MDSO) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDIDATA SOLUTIONS INC (MDSO) Stock Chart to make your own analysis
- MEDIDATA SOLUTIONS INC (MDSO) Latest news and press-releases to stay up to date.
Does MEDIDATA SOLUTIONS INC (MDSO) stock pay dividends?
MDSO does not pay a dividend.
What is the Price/Earnings (PE) ratio of MEDIDATA SOLUTIONS INC (MDSO)?
The PE ratio for MEDIDATA SOLUTIONS INC (MDSO) is 106. This is based on the reported non-GAAP earnings per share of 0.87 and the current share price of 92.22 null. Check the full fundamental report for a full analysis of the valuation metrics for MDSO.
MDSO Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to MDSO. When comparing the yearly performance of all stocks, MDSO is one of the better performing stocks in the market, outperforming 83.65% of all stocks.
MDSO Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MDSO. MDSO has an excellent financial health rating, but there are some minor concerns on its profitability.
MDSO Financial Highlights
Over the last trailing twelve months MDSO reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS decreased by -10.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.43% | ||
| ROA | 4.3% | ||
| ROE | 6.67% | ||
| Debt/Equity | 0.27 |
MDSO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to MDSO. The Buy consensus is the average rating of analysts ratings from 9 analysts.